Tianjin Rohto Chinese Medicine

Tianjin Rohto Chinese Medicine is a prominent pharmaceutical joint venture established in 1995 between Japan's Rohto Pharmaceutical and the Tianjin Pharmaceutical Da Ren Tang Group. The company is a leader in the Chinese over-the-counter (OTC) ophthalmic market, best known for its flagship product, New V.Rohto eye drops, which are widely used to treat eye strain and congestion. Operating from a state-of-the-art manufacturing facility in the Tianjin Economic-Technological Development Area (TEDA), the company adheres to strict international Good Manufacturing Practice (GMP) standards. Its product portfolio extends beyond eye care to include dermatological treatments and skincare products, leveraging both Japanese pharmaceutical technology and local Traditional Chinese Medicine (TCM) expertise. By integrating advanced production standards with deep market insights, Tianjin Rohto has maintained a strong commercial presence in China for nearly three decades.